Author

Philipp Abe

University Hospital Carl Gustav CarusPrimary ORCID profile (0000-0002-8067-1802 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Philipp AbeiD5 papers · University of Geneva

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Andreas DahliD· 1 shared Beatrice WasseriD· 1 shared Carina FabianiD· 1 shared Eirini Moysoglou· 1 shared Fanny EhretiD· 1 shared Frauke ZippiD· 1 shared Julieta ApreaiD· 1 shared Kathrin Barth· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas DahlORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EGFL7 promotes immune evasion in glioblastoma by interaction with integrin β2

Sukrit Mahajan, Philipp Abe, Fanny Ehret, Carina Fabian, Nora Heinig, Marc Gentzel, Rajinder Gupta, Julieta Aprea, Paul Warnke, Eirini Moysoglou, Beatrice Wasser, Stephan Grabbe, Andreas Dahl, Kathrin Barth, Marc Schmitz, , Mirko H. H. Schmidt

This study identifies EGFL7 as a driver of immune evasion in glioblastoma by interacting with integrin β2, showing that targeting this axis enhances immunotherapy efficacy.

bioRxiv · Jul 28, 2025 · PreprintCancer Biology